title: [Efficacy of fludarabine in the treatment of angioimmunoblastic lymphoma (AIL)].
authors.affiliation: Unité de Médecine Interne et d'Hématologie, Hôpital Saint-Vincent, boulevard de Belfort, 59000 Lille, France.
authors.forename: E
authors.initials: E
authors.lastname: Bourgeois
authors.forename: E
authors.initials: E
authors.lastname: Auxenfants
authors.forename: C
authors.initials: C
authors.lastname: Jouffrey
authors.forename: C
authors.initials: C
authors.lastname: Dubest
authors.forename: M
authors.initials: M
authors.lastname: Mahieu
authors.forename: C
authors.initials: C
authors.lastname: Rose
mesh_terms: D006801:Humans; D007119:Immunoblastic Lymphadenopathy / Q000188:drug therapy*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D007166:Immunosuppressive Agents; D014740:Vidarabine; C024352:fludarabine